» Articles » PMID: 29520257

Vaccine Development Against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2018 Mar 10
PMID 29520257
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis E virus (HEV) is a fecal-orally transmitted foodborne viral pathogen that causes acute hepatitis in humans and is responsible for hepatitis E outbreaks worldwide. Since the discovery of HEV as a zoonotic agent, this virus has been isolated from a variety of hosts with an ever-expanding host range. Recently, a subunit HEV vaccine developed for the prevention of human disease was approved in China, but is not yet available to the rest of the world. Meanwhile, notable progress and knowledge has been made and revealed in recent years to better understand HEV biology and infection, including discoveries of quasi-enveloped HEV virions and of a new function of the HEV-ORF3 product. However, the impact of these new findings on the development of a protective vaccine against zoonotic HEV infection requires further discussion. In this review, hallmark characteristics of HEV zoonosis, the history of HEV vaccine development, and recent discoveries in HEV virology are described. Moreover, special attention is focused on quasi-enveloped HEV virions and the potential role of the HEV-ORF3 product as antibody-neutralization target on the surface of quasi-enveloped HEV virions to provide new insights for the future development of improved vaccines against zoonotic HEV infection.

Citing Articles

Trends and projections of Hepatitis A incidence in eastern China from 2007 to 2021: an age-period-cohort analysis.

Peng H, Wang Y, Wei S, Kang W, Zhang X, Cheng X Front Public Health. 2024; 12:1476748.

PMID: 39697280 PMC: 11652658. DOI: 10.3389/fpubh.2024.1476748.


Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals.

Chen Y, Zhang M, Chen T, Wang J, Zhao Q, Zhou E Microbiol Spectr. 2023; 11(4):e0360722.

PMID: 37347160 PMC: 10434039. DOI: 10.1128/spectrum.03607-22.


Prediction of promiscuous epitopes in ORF2 of Hepatitis E virus: an approach.

Samavia N, Fahed P, Yasir W, Tasneem A, Syeda N Afr Health Sci. 2023; 22(3):626-639.

PMID: 36910344 PMC: 9993254. DOI: 10.4314/ahs.v22i3.67.


Identification of two novel neutralizing nanobodies against swine hepatitis E virus.

Chen Y, Wang X, Zhang M, Li J, Gao X, Nan Y Front Microbiol. 2022; 13:1048180.

PMID: 36504801 PMC: 9727072. DOI: 10.3389/fmicb.2022.1048180.


Hepatitis E genotype 3 genome: A comprehensive analysis of entropy, motif conservation, relevant mutations, and clade-associated polymorphisms.

Munoz-Chimeno M, Rodriguez-Paredes V, Garcia-Lugo M, Avellon A Front Microbiol. 2022; 13:1011662.

PMID: 36274715 PMC: 9582770. DOI: 10.3389/fmicb.2022.1011662.


References
1.
Nagashima S, Takahashi M, Jirintai S, Tanaka T, Nishizawa T, Yasuda J . Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J Gen Virol. 2011; 92(Pt 12):2838-2848. DOI: 10.1099/vir.0.035378-0. View

2.
Lhomme S, Dubois M, Abravanel F, Top S, Bertagnoli S, Guerin J . Risk of zoonotic transmission of HEV from rabbits. J Clin Virol. 2013; 58(2):357-62. PMC: 7172140. DOI: 10.1016/j.jcv.2013.02.006. View

3.
Kabrane-Lazizi Y, Zhang M, Purcell R, Miller K, Davey R, Emerson S . Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains. J Gen Virol. 2001; 82(Pt 7):1687-1693. DOI: 10.1099/0022-1317-82-7-1687. View

4.
Zhou E, Guo H, Huang F, Sun Z, Meng X . Identification of two neutralization epitopes on the capsid protein of avian hepatitis E virus. J Gen Virol. 2008; 89(Pt 2):500-508. DOI: 10.1099/vir.0.83366-0. View

5.
Xia J, Zeng H, Liu L, Zhang Y, Liu P, Geng J . Swine and rabbits are the main reservoirs of hepatitis E virus in China: detection of HEV RNA in feces of farmed and wild animals. Arch Virol. 2015; 160(11):2791-8. DOI: 10.1007/s00705-015-2574-0. View